检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]同济大学附属第十人民医院心血管内科,上海200072
出 处:《同济大学学报(医学版)》2017年第1期119-123,共5页Journal of Tongji University(Medical Science)
基 金:国家自然科学基金(81270256);上海市科委医学引导类项目(16411965700)
摘 要:心房颤动是最常见的持续性心律失常并增加缺血性卒中风险,长期口服抗凝药物治疗是预防房颤患者卒中较为常规的治疗手段,但许多房颤患者存在抗凝治疗的绝对或相对禁忌证。左心耳封堵术(left atrial appendage closure,LAAC)为栓塞高危伴出血高危或口服抗凝药(oral anticoagulation,OAC)禁忌者提供了另外一种选择。预防LAAC术后封堵器血栓形成以及减少出血事件对于成功的LAAC术至关重要。因此选择合适的术后抗栓策略尤为关键。Atrial fibrillation (AF) is the most common sustained arrhythmia, which increases the risk of ischemic stroke. Long-term oral antithrombotic therapy has been widespread used as a major strategy in patients at high risk of ischemic stroke in association with atrial fibrillation, but many patients cannot achieve anticoagulation targets due to contraindications to its application or bleeding. Left atrial appendage closure (LAAC) has emerged as an alternative treatment for patients with atrial fibrillation who are at high risk of ischemic stroke and have contraindications for anticoagulation. It is important to prevent on-device thrombus formation without increasing the risk for bleeding complications after successful interventional left atrial appendage closure. Therefore, choosing the optimal antithrombotic therapy is very important after LAAC.
分 类 号:R541.7[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.63